BNR — Burning Rock Biotech Cashflow Statement
0.000.00%
- $62.59m
- -$17.62m
- CNY537.44m
- 68
- 59
- 36
- 54
Annual cashflow statement for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -169 | -407 | -797 | -971 | -654 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 40.2 | 185 | 333 | 401 | 317 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -130 | 116 | -62.4 | -11.2 | -52.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -228 | -73.5 | -478 | -457 | -256 |
Capital Expenditures | -45.7 | -79.5 | -213 | -75.5 | -9.38 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -301 | -29.8 | 295 | 68 | 0.084 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -347 | -109 | 81.7 | -7.46 | -9.3 |
Financing Cash Flow Items | — | 0.701 | -3.82 | -12 | -41.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 572 | 2,166 | -52.9 | -86.2 | -48.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.91 | 1,827 | -486 | -514 | -310 |